| Report ID |
35644 |
| Drug Identification Number |
02091887 |
| Brand name |
RIFADIN |
| Common or Proper name |
Rifadin 150mg |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
DORMANT |
| Active Ingredient(s) |
RIFAMPIN |
| Strength(s) |
150MG |
| Dosage form(s) |
CAPSULE |
| Route of administration |
ORAL |
| Packaging size |
100's |
| ATC code |
J04AB |
| ATC description |
DRUGS FOR TREATMENT OF TUBERCULOSIS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
|
| Actual start date |
2018-01-05 |
| Estimated end date |
2018-01-30 |
| Actual end date |
2018-01-31 |
| Shortage status |
Resolved |
| Updated date |
2018-02-02 |
| Company comments |
Delay in supply |
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
